How does ionizing irradiation contribute to the induction of anti-tumor immunity?

Frontiers in Oncology

Volumn 2 JUL, Issue , 2012, Pages

  Rubner, Yvonne ^a   Wunderlich, Roland ^a   Rühle, Paul Friedrich ^a   Kulzer, Lorenz ^a   Werthmöller, Nina ^a   Frey, Benjamin ^a   Weiss, Eva Maria ^a   Keilholz, Ludwig ^b   Fietkau, Rainer ^a   Gaipl, Udo S ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b Clinical Center Bayreuth   (Germany)

Author keywords

Abscopal effects; AnnexinA5; Dendritic cells; Hyperthermia; Immune modulation; Immune therapy; Immunogenic cancer cell death; Low and high dose ionizing irradiation

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; LIPOCORTIN 5; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ABSCOPAL EFFECT; ANTINEOPLASTIC ACTIVITY; CANCER CONTROL; CELL PROLIFERATION; HUMAN; HYPERTHERMIA; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; IONIZING RADIATION; MACROPHAGE ACTIVATION; NEOPLASM; NONHUMAN; REVIEW; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT; X RAY;

EID: 84876416160     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2012.00075     Document Type: Review

References (112)

1. Abramson, S. B., Amin, A. R., Clancy, R. M., and Attur, M. (2001). The role of nitric oxide in tissue destruction. Best Pract. Res. Clin. Rheumatol. 15, 831-845.
2. Akutsu, Y., Matsubara, H., Urashima, T., Komatsu, A., Sakata, H., Nishimori, T., Yoneyama, Y., Hoshino, I., Murakami, K., Usui, A., Kano, M., and Ochiai, T. (2007). Combination of direct intratumoral administration of dendritic cells and irradiation induces strong systemic antitumor effect mediated by GRP94/gp96 against squamous cell carcinoma in mice. Int. J. Oncol. 31, 509-515.
3. Anders, H. J., and Ryu, M. (2011). Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis. Kidney Int. 80, 915-925.
4. Anderson, R. E., and Warner, N. L. (1976). Ionizing radiation and the immune response. Adv. Immunol. 24, 215-335.
5. Antoniades, J., Brady, L. W., and Lightfoot, D. A. (1977). Lymphangiographic demonstration of the abscopal effect in patients with malignant lymphomas. Int. J. Radiat. Oncol. Biol. Phys. 2, 141-147.
6. Apetoh, L., Ghiringhelli, F., Tesniere, A., Criollo, A., Ortiz, C., Lidereau, R., Mariette, C., Chaput, N., Mira, J. P., Delaloge, S., Andre, F., Tursz, T., Kroemer, G., and Zitvogel, L. (2007). The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy. Immunol. Rev. 220, 47-59.
7. Atkinson, W. D., Law, D. V., Bromley, K. J., and Inskip, H. M. (2004). Mortality of employees of the United Kingdom Atomic Energy Authority, 1946-97. Occup. Environ. Med. 61, 577-585.
8. Azzam, E. I., De Toledo, S. M., and Little, J. B. (2001). Direct evidence for the participation of gap junction-mediated intercellular communication in the transmission of damage signals from alpha-particle irradiated to nonirradiated cells. Proc. Natl. Acad. Sci. U.S.A. 98, 473-478.
9. Basu, S., Binder, R. J., Suto, R., Anderson, K. M., and Srivastava, P. K. (2000). Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. Int. Immunol. 12, 1539-1546.
10. Bauer, M., Goldstein, M., Christmann, M., Becker, H., Heylmann, D., and Kaina, B. (2011). Human monocytes are severely impaired in base and DNA double-strand break repair that renders them vulnerable to oxidative stress. Proc. Natl. Acad. Sci. U.S.A. 108, 21105-21110.
11. Beyer, C., Stearns, N. A., Giessl, A., Distler, J. H., Schett, G., and Pisetsky, D. (2012). The extracellular release of DNA and HMGB1 from Jurkat T cells during in vitro necrotic cell death. Innate Immun. 16, 16.
12. Boice, J. D. Jr., Mumma, M. T., and Blot, W. J. (2006). Cancer mortality among populations residing in counties near the Hanford site, 1950-2000. Health Phys. 90, 431-445.
13. Bondanza, A., Zimmermann, V. S., Rovere-Querini, P., Turnay, J., Dumitriu, I. E., Stach, C. M., Voll, R. E., Gaipl, U. S., Bertling, W., Poschl, E., Kalden, J. R., Manfredi, A. A., and Herrmann, M. (2004). Inhibition of phosphatidylserine recognition heightens the immunogenicity of irradiated lymphoma cells in vivo. J. Exp. Med. 200, 1157-1165.
14. Burd, R., Dziedzic, T. S., Xu, Y., Caligiuri, M. A., Subjeck, J. R., and Repasky, E. A. (1998). Tumor cell apoptosis, lymphocyte recruitment and tumor vascular changes are induced by low temperature, long duration (fever-like) whole body hyperthermia. J. Cell. Physiol. 177, 137-147.
15. Camphausen, K., Moses, M. A., Menard, C., Sproull, M., Beecken, W. D., Folkman, J., and O'Reilly, M. S. (2003). Radiation abscopal antitumor effect is mediated through p53. Cancer Res. 63, 1990-1993.
16. Chen, T., Guo, J., Han, C., Yang, M., and Cao, X. (2009). Heat shock protein 70, released from heat-stressed tumor cells, initiates antitumor immunity by inducing tumor cell chemokine production and activating dendritic cells via TLR4 pathway. J. Immunol. 182, 1449-1459.
17. Conrad, S., Ritter, S., Fournier, C., and Nixdorff, K. (2009). Differential effects of irradiation with carbon ions and x-rays on macrophage function. J. Radiat. Res. 50, 223-231.
18. Demaria, S., Ng, B., Devitt, M. L., Babb, J. S., Kawashima, N., Liebes, L., and Formenti, S. C. (2004). Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated. Int. J. Radiat. Oncol. Biol. Phys. 58, 862-870.
19. Derose, P., Thorpe, P. E., and Gerber, D. E. (2011). Development of bavituximab, a vascular targeting agent with immune-modulating properties, for lung cancer treatment. Immunotherapy 3, 933-944.
20. Dewan, M. Z., Galloway, A. E., Kawashima, N., Dewyngaert, J. K., Babb, J. S., Formenti, S. C., and Demaria, S. (2009). Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody. Clin. Cancer Res. 15, 5379-5388.
21. Dong, J., Bohinski, R. J., Li, Y. Q., Van Waes, C., Hendler, F., Gleich, L., and Stambrook, P. J. (2003). Antitumor effect of secreted Flt3-ligand can act at distant tumor sites in a murine model of head and neck cancer. Cancer Gene Ther. 10, 96-104.
22. Everse, L. A., Renes, I. B., Jurgenliemk-Schulz, I. M., Rutgers, D. H., Bernsen, M. R., Dullens, H. F., Den Otter, W., and Battermann, J. J. (1997). Local low-dose interleukin-2 induces systemic immunity when combined with radiotherapy of cancer. A pre-clinical study. Int. J. Cancer 72, 1003-1007.
23. Frey, B., and Gaipl, U. S. (2011). The immune functions of phosphatidylserine in membranes of dying cells and microvesicles. Semin. Immunopathol. 33, 497-516.
24. Frey, B., Rubner, Y., Wunderlich, R., Weiss, E. M., Pockley, A. G., Fietkau, R., and Gaipl, U. S. (2012). Induction of abscopal anti-tumor immunity and immunogenic tumor cell death by ionizing irradiation-implications for cancer therapies. Curr. Med. Chem. 12, 1751-1764.
25. Frey, B., Schildkopf, P., Rodel, F., Weiss, E. M., Munoz, L. E., Herrmann, M., Fietkau, R., and Gaipl, U. S. (2009). AnnexinA5 renders dead tumor cells immunogenic-implications for multimodal cancer therapies. J. Immunotoxicol. 6, 209-216.
26. Fujihara, M., Muroi, M., Tanamoto, K., Suzuki, T., Azuma, H., and Ikeda, H. (2003). Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex. Pharmacol. Ther. 100, 171-194.
27. Gaipl, U. S., Meister, S., Lodermann, B., Rodel, F., Fietkau, R., Herrmann, M., Kern, P. M., and Frey, B. (2009). Activation-induced cell death and total Akt content of granulocytes show a biphasic course after low-dose radiation. Autoimmunity 42, 340-342.
28. Gaipl, U. S., Munoz, L. E., Rodel, F., Pausch, F., Frey, B., Brachvogel, B., Von Der Mark, K., and Poschl, E. (2007). Modulation of the immune system by dying cells and the phosphatidylserine-ligand annexin A5. Autoimmunity 40, 254-259.
29. He, J., Luster, T. A., and Thorpe, P. E. (2007). Radiation-enhanced vascular targeting of human lung cancers in mice with a monoclonal antibody that binds anionic phospholipids. Clin. Cancer Res. 13, 5211-5218.
30. He, J., Yin, Y., Luster, T. A., Watkins, L., and Thorpe, P. E. (2009). Antiphosphatidylserine antibody combined with irradiation damages tumor blood vessels and induces tumor immunity in a rat model of glioblastoma. Clin. Cancer Res. 15, 6871-6880.
31. Hildebrandt, G., Loppnow, G., Jahns, J., Hindemith, M., Anderegg, U., Saalbach, A., and Kamprad, F. (2003). Inhibition of the iNOS pathway in inflammatory macrophages by low-dose X-irradiation in vitro. Is there a time dependence? Strahlenther. Onkol. 179, 158-166.
32. Hildebrandt, G., Seed, M. P., Freemantle, C. N., Alam, C. A., Colville-Nash, P. R., and Trott, K. R. (1998). Mechanisms of the anti-inflammatory activity of low-dose radiation therapy. Int. J. Radiat. Biol. 74, 367-378.
33. Hodge, J. W., Guha, C., Neefjes, J., and Gulley, J. L. (2008). Synergizing radiation therapy and immunotherapy for curing incurable cancers. Opportunities and challenges. Oncology (Williston Park, N.Y.) 22, 1064-1070; discussion 1075, 1080-1081, 1084.
34. Hodi, F. S., O'Day, S. J., Mcdermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., Akerley, W., Van Den Eertwegh, A. J., Lutzky, J., Lorigan, P., Vaubel, J. M., Linette, G. P., Hogg, D., Ottensmeier, C. H., Lebbe, C., Peschel, C., Quirt, I., Clark, J. I., Wolchok, J. D., Weber, J. S., Tian, J., Yellin, M. J., Nichol, G. M., Hoos, A., and Urba, W. J. (2010). Improved survival with ipilimumab in patients with metastatic melanoma. N. Engl. J. Med. 363, 711-723.
35. Hosoi, Y., and Sakamoto, K. (1993). Suppressive effect of low dose total body irradiation on lung metastasis: dose dependency and effective period. Radiother. Oncol. 26, 177-179.
36. Hoves, S., Sutton, V. R., Haynes, N. M., Hawkins, E. D., Fernandez Ruiz, D., Baschuk, N., Sedelies, K. A., Schnurr, M., Stagg, J., Andrews, D. M., Villadangos, J. A., and Trapani, J. A. (2011). A critical role for granzymes in antigen cross-presentation through regulating phagocytosis of killed tumor cells. J. Immunol. 187, 1166-1175.
37. Huang, Q., Li, F., Liu, X., Li, W., Shi, W., Liu, F. F., O'Sullivan, B., He, Z., Peng, Y., Tan, A. C., Zhou, L., Shen, J., Han, G., Wang, X. J., Thorburn, J., Thorburn, A., Jimeno, A., Raben, D., Bedford, J. S., and Li, C. Y. (2011). Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy. Nat. Med. 17, 860-866.
38. Hume, D. A. (2006). The mononuclear phagocyte system. Curr. Opin. Immunol. 18, 49-53.
39. Ina, Y., Tanooka, H., Yamada, T., and Sakai, K. (2005). Suppression of thymic lymphoma induction by life-long low-dose-rate irradiation accompanied by immune activation in C57BU6 mice. Radiat. Res. 163, 153-158.
40. Isobe, Y., Aritaka, N., Sasaki, M., Oshimi, K., and Sugimoto, K. (2009). Spontaneous regression of natural killer cell lymphoma. J. Clin. Pathol. 62, 647-650.
41. Iyer, R., Lehnert, B. E., and Svensson, R. (2000). Factors underlying the cell growth-related bystander responses to alpha particles. Cancer Res. 60, 1290-1298.
42. James, S. J., and Makinodan, T. (1988). T cell potentiation in normal and autoimmune-prone mice after extended exposure to low doses of ionizing radiation and/or caloric restriction. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 53, 137-152.
43. Jin, S. Z., Pan, X. N., Wu, N., Jin, G. H., and Liu, S. Z. (2007). Whole-body low dose irradiation promotes the efficacy of conventional radiotherapy for cancer and possible mechanisms. Dose Response 5, 349-358.
44. Jurgenliemk-Schulz, I. M., Renes, I. B., Rutgers, D. H., Everse, L. A., Bernsen, M. R., Den Otter, W., and Battermann, J. J. (1997). Anti-tumor effects of local irradiation in combination with peritumoral administration of low doses of recombinant interleukin-2 (rIL-2). Radiat. Oncol. Investig. 5, 54-61.
45. Kepp, O., Tesniere, A., Schlemmer, F., Michaud, M., Senovilla, L., Zitvogel, L., and Kroemer, G. (2009). Immunogenic cell death modalities and their impact on cancer treatment. Apoptosis 14, 364-375.
46. Kern, P., Keilholz, L., Forster, C., Seegenschmiedt, M. H., Sauer, R., and Herrmann, M. (1999). In vitro apoptosis in peripheral blood mononuclear cells induced by low-dose radiotherapy displays a discontinuous dose-dependence. Int. J. Radiat. Biol. 75, 995-1003.
47. Kim, K. W., Kim, S. H., Shin, J. G., Kim, G. S., Son, Y. O., Park, S. W., Kwon, B. H., Kim, D. W., Lee, C. H., Sol, M. Y., Jeong, M. H., Chung, B. S., and Kang, C. D. (2004). Direct injection of immature dendritic cells into irradiated tumor induces efficient antitumor immunity. Int. J. Cancer 109, 685-690.
48. Kingsley, D. P. (1975). An interesting case of possible abscopal effect in malignant melanoma. Br. J. Radiol. 48, 863-866.
49. Konoeda, K. (1990). Therapeutic efficacy of pre-operative radiotherapy on breast carcinoma: in special reference to its abscopal effect on metastatic lymph-nodes. Nihon Gan Chiryo Gakkai Shi 25, 1204-1214.
50. Kwong, Y. L., Chen, S. H., Kosai, K., Finegold, M., and Woo, S. L. (1997). Combination therapy with suicide and cytokine genes for hepatic metastases of lung cancer. Chest 112, 1332-1337.
51. Lauber, K., Bohn, E., Krober, S. M., Xiao, Y. J., Blumenthal, S. G., Lindemann, R. K., Marini, P., Wiedig, C., Zobywalski, A., Baksh, S., Xu, Y., Autenrieth, I. B., Schulze-Osthoff, K., Belka, C., Stuhler, G., and Wesselborg, S. (2003). Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell 113, 717-730.
52. Lauber, K., Munoz, L. E., Berens, C., Jendrossek, V., Belka, C., and Herrmann, M. (2011). Apoptosis induction and tumor cell repopulation: the yin and yang of radiotherapy. Radiat. Oncol. 6, 176.
53. Lee, Y., Auh, S. L., Wang, Y., Burnette, B., Meng, Y., Beckett, M., Sharma, R., Chin, R., Tu, T., Weichselbaum, R. R., and Fu, Y. X. (2009). Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment. Blood 114, 589-595.
54. Liu, S. Z. (2003). On radiation hormesis expressed in the immune system. Crit. Rev. Toxicol. 33, 431-441.
55. Liu, S. Z. (2007). Cancer control related to stimulation of immunity by low-dose radiation. Dose Response 5, 39-47.
56. Liu, S. Z., Liu, W. H., and Sun, J. B. (1987). Radiation hormesis: its expression in the immune system. Health Phys. 52, 579-583.
57. Lodermann, B., Wunderlich, R., Frey, S., Schorn, C., Stangl, S., Rodel, F., Keilholz, L., Fietkau, R., Gaipl, U. S., and Frey, B. (2012). Low dose ionising radiation leads to a NF-kappaB dependent decreased secretion of active IL-1beta by activated macrophages with a discontinuous dose-dependency. Int. J. Radiat. Biol. PMID:22545750. [Epub ahead of print].
58. Lugade, A. A., Moran, J. P., Gerber, S. A., Rose, R. C., Frelinger, J. G., and Lord, E. M. (2005). Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor. J. Immunol. 174, 7516-7523.
59. Ma, Y., Kepp, O., Ghiringhelli, F., Apetoh, L., Aymeric, L., Locher, C., Tesniere, A., Martins, I., Ly, A., Haynes, N. M., Smyth, M. J., Kroemer, G., and Zitvogel, L. (2010). Chemotherapy and radiotherapy: cryptic anticancer vaccines. Semin. Immunol. 22, 113-124.
60. Mantel, F., Frey, B., Haslinger, S., Schildkopf, P., Sieber, R., Ott, O. J., Lodermann, B., Rodel, F., Sauer, R., Fietkau, R., and Gaipl, U. S. (2010). Combination of ionising irradiation and hyperthermia activates programmed apoptotic and necrotic cell death pathways in human colorectal carcinoma cells. Strahlenther. Onkol. 186, 587-599.
61. Martin, P., and Leibovich, S. J. (2005). Inflammatory cells during wound repair: the good, the bad and the ugly. Trends Cell Biol. 15, 599-607.
62. Matzinger, P. (1994). Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12, 991-1045.
63. McGeoghegan, D., and Binks, K. (2001). The mortality and cancer morbidity experience of employees at the Chapelcross plant of British Nuclear Fuels plc, 1955-95. J. Radiol. Prot. 21, 221-250.
64. Mellman, I., Coukos, G., and Dranoff, G. (2011). Cancer immunotherapy comes of age. Nature 480, 480-489.
65. Mole, R. H. (1953). Whole body irradiation; radiobiology or medicine? Br. J. Radiol. 26, 234-241.
66. Mueller, N. (1999). Overview of the epidemiology of malignancy in immune deficiency. J. Acquir. Immune Defic. Syndr. 21, S5-S10.
67. Nobler, M. P. (1969). The abscopal effect in malignant lymphoma and its relationship to lymphocyte circulation. Radiology 93, 410-412.
68. Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Apetoh, L., Perfettini, J. L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., Metivier, D., Larochette, N., Van Endert, P., Ciccosanti, F., Piacentini, M., Zitvogel, L., and Kroemer, G. (2007). Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat. Med. 13, 54-61.
69. Ohba, K., Omagari, K., Nakamura, T., Ikuno, N., Saeki, S., Matsuo, I., Kinoshita, H., Masuda, J., Hazama, H., Sakamoto, I., and Kohno, S. (1998). Abscopal regression of hepatocellular carcinoma after radiotherapy for bone metastasis. Gut 43, 575-577.
70. Okuma, K., Yamashita, H., Niibe, Y., Hayakawa, K., and Nakagawa, K. (2011). Abscopal effect of radiation on lung metastases of hepatocellular carcinoma: a case report. J. Med. Case Reports 5, 111.
71. Pages, F., and Kroemer, G. (2011). Prognostic impact of anticancer immune responses: an introduction. Semin. Immunopathol. 33, 317-319.
72. Pisetsky, D. S., Gauley, J., and Ullal, A. J. (2011). HMGB1 and microparticles as mediators of the immune response to cell death. Antioxid. Redox Signal. 15, 2209-2219.
73. Postow, M. A., Callahan, M. K., Barker, C. A., Yamada, Y., Yuan, J., Kitano, S., Mu, Z., Rasalan, T., Adamow, M., Ritter, E., Sedrak, C., Jungbluth, A. A., Chua, R., Yang, A. S., Roman, R. A., Rosner, S., Benson, B., Allison, J. P., Lesokhin, A. M., Gnjatic, S., and Wolchok, J. D. (2012). Immunologic correlates of the abscopal effect in a patient with melanoma. N. Engl. J. Med. 366, 925-931.
74. Prasad, A. V., Mohan, N., Chandrasekar, B., and Meltz, M. L. (1994). Activation of nuclear factor kappa B in human lymphoblastoid cells by low-dose ionizing radiation. Radiat. Res. 138, 367-372.
75. Prasad, A. V., Mohan, N., Chandrasekar, B., and Meltz, M. L. (1995). Induction of transcription of "immediate early genes" by low-dose ionizing radiation. Radiat. Res. 143, 263-272.
76. Reits, E. A., Hodge, J. W., Herberts, C. A., Groothuis, T. A., Chakraborty, M., Wansley, E. K., Camphausen, K., Luiten, R. M., De Ru, A. H., Neijssen, J., Griekspoor, A., Mesman, E., Verreck, F. A., Spits, H., Schlom, J., Van Veelen, P., and Neefjes, J. J. (2006). Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy. J. Exp. Med. 203, 1259-1271.
77. Riedl, S., Rinner, B., Asslaber, M., Schaider, H., Walzer, S., Novak, A., Lohner, K., and Zweytick, D. (2011). In search of a novel target-phosphatidylserine exposed by non-apoptotic tumor cells and metastases of malignancies with poor treatment efficacy. Biochim. Biophys. Acta 1808, 2638-2645.
78. Robert, C., Thomas, L., Bondarenko, I., O'Day, S., Weber, J., Garbe, C., Lebbe, C., Baurain, J. F., Testori, A., Grob, J. J., Davidson, N., Richards, J., Maio, M., Hauschild, A., Miller, W. H. Jr., Gascon, P., Lotem, M., Harmankaya, K., Ibrahim, R., Francis, S., Chen, T. T., Humphrey, R., Hoos, A., and Wolchok, J. D. (2011). Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. N. Engl. J. Med. 364, 2517-2526.
79. Rodel, F., Frey, B., Gaipl, U., Keilholz, L., Fournier, C., Manda, K., Schollnberger, H., Hildebrandt, G., and Rodel, C. (2012). Modulation of inflammatory immune reactions by low-dose ionizing radiation: molecular mechanisms and clinical application. Curr. Med. Chem. 19, 1741-1750.
80. Rodel, F., Hantschel, M., Hildebrandt, G., Schultze-Mosgau, S., Rodel, C., Herrmann, M., Sauer, R., and Voll, R. E. (2004a). Dose-dependent biphasic induction and transcriptional activity of nuclear factor kappa B (NF-kappaB) in EA.hy.926 endothelial cells after low-dose X-irradiation. Int. J. Radiat. Biol. 80, 115-123.
81. Rodel, F., Schaller, U., Schultze-Mosgau, S., Beuscher, H. U., Keilholz, L., Herrmann, M., Voll, R., Sauer, R., and Hildebrandt, G. (2004b). The induction of TGF-beta(1) and NF-kappaB parallels a biphasic time course of leukocyte/endothelial cell adhesion following low-dose X-irradiation. Strahlenther. Onkol. 180, 194-200.
82. Rodel, F., Kamprad, F., Sauer, R., and Hildebrandt, G. (2002). Functional and molecular aspects of anti-inflammatory effects of low-dose radiotherapy. Strahlenther. Onkol. 178, 1-9.
83. Rodel, F., Keilholz, L., Herrmann, M., Weiss, C., Frey, B., Voll, R., Gaipl, U., and Rodel, C. (2009). Activator protein 1 shows a biphasic induction and transcriptional activity after low dose X-irradiation in EA.hy.926 endothelial cells. Autoimmunity 42, 343-345.
84. Roedel, F., Kley, N., Beuscher, H. U., Hildebrandt, G., Keilholz, L., Kern, P., Voll, R., Herrmann, M., and Sauer, R. (2002). Anti-inflammatory effect of low-dose X-irradiation and the involvement of a TGF-beta1-induced down-regulation of leukocyte/endothelial cell adhesion. Int. J. Radiat. Biol. 78, 711-719.
85. Salomaa, S. I., Wright, E. G., Hildebrandt, G., Kadhim, M. A., Little, M. P., Prise, K. M., and Belyakov, O.V. (2010). Editorial. Non-DNA targeted effects. Mutat. Res. 687, 1-2.
86. Santin, A. D., Hermonat, P. L., Hiserodt, J. C., Chiriva-Internati, M., Woodliff, J., Theus, J. W., Barclay, D., Pecorelli, S., and Parham, G. P. (1997). Effects of irradiation on the expression of major histocompatibility complex class I antigen and adhesion costimulation molecules ICAM-1 in human cervical cancer. Int. J. Radiat. Oncol. Biol. Phys. 39, 737-742.
87. Sauter, B., Albert, M. L., Francisco, L., Larsson, M., Somersan, S., and Bhardwaj, N. (2000). Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 191, 423-434.
88. Schaue, D., Marples, B., and Trott, K. R. (2002). The effects of low-dose X-irradiation on the oxidative burst in stimulated macrophages. Int. J. Radiat. Biol. 78, 567-576.
89. Schildkopf, P., Frey, B., Mantel, F., Ott, O. J., Weiss, E. M., Sieber, R., Janko, C., Sauer, R., Fietkau, R., and Gaipl, U. S. (2009a). Application of hyperthermia in addition to ionizing irradiation fosters necrotic cell death and HMGB1 release of colorectal tumor cells. Biochem. Biophys. Res. Commun. 391, 1014-1020.
90. Schildkopf, P., Holmer, R., Sieber, R., Ott, O. J., Janko, C., Mantel, F., Frey, B., Fietkau, R., and Gaipl, U. S. (2009b). Hyperthermia in combination with X-irradiation induces inflammatory forms of cell death. Autoimmunity 42, 311-313.
91. Schildkopf, P., Frey, B., Ott, O. J., Rubner, Y., Multhoff, G., Sauer, R., Fietkau, R., and Gaipl, U. S. (2011). Radiation combined with hyperthermia induces HSP70-dependent maturation of dendritic cells and release of pro-inflammatory cytokines by dendritic cells and macrophages. Radiother. Oncol. 101, 109-115.
92. Schueller, G., Stift, A., Friedl, J., Dubsky, P., Bachleitner-Hofmann, T., Benkoe, T., Jakesz, R., and Gnant, M. (2003). Hyperthermia improves cellular immune response to human hepatocellular carcinoma subsequent to co-culture with tumor lysate pulsed dendritic cells. Int. J. Oncol. 22, 1397-1402.
93. Serhatlioglu, S., Ogur, E., Ozan, A. T., Gursu, F., Godekmerdan, A., and Ayar, A. (2004). Biochemical and immunological effects of ionizing radiation in radiology staff members. Tani. Girisim. Radyol. 10, 97-102.
94. Sham, R. L. (1995). The abscopal effect and chronic lymphocytic leukemia. Am. J. Med. 98, 307-308.
95. Shankaran, V., Ikeda, H., Bruce, A. T., White, J. M., Swanson, P. E., Old, L. J., and Schreiber, R. D. (2001). IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 410, 1107-1111.
96. Shin, S. C., Lee, K. M., Kang, Y. M., Kim, K., Kim, C. S., Yang, K. H., Jin, Y. W., and Kim, H. S. (2010). Alteration of cytokine profiles in mice exposed to chronic low-dose ionizing radiation. Biochem. Biophys. Res. Commun. 397, 644-649.
97. Shiraishi, K., Ishiwata, Y., Nakagawa, K., Yokochi, S., Taruki, C., Akuta, T., Ohtomo, K., Matsushima, K., Tamatani, T., and Kanegasaki, S. (2008). Enhancement of antitumor radiation efficacy and consistent induction of the abscopal effect in mice by ECI301, an active variant of macrophage inflammatory protein-1alpha. Clin. Cancer Res. 14, 1159-1166.
98. Somersan, S., Larsson, M., Fonteneau, J. F., Basu, S., Srivastava, P., and Bhardwaj, N. (2001). Primary tumor tissue lysates are enriched in heat shock proteins and induce the maturation of human dendritic cells. J. Immunol. 167, 4844-4852.
99. Stangl, S., Gross, C., Pockley, A. G., Asea, A. A., and Multhoff, G. (2008). Influence of Hsp70 and HLA-E on the killing of leukemic blasts by cytokine/Hsp70 peptide-activated human natural killer (NK) cells. Cell Stress Chaperones 13, 221-230.
100. Takeshima, T., Chamoto, K., Wakita, D., Ohkuri, T., Togashi, Y., Shirato, H., Kitamura, H., and Nishimura, T. (2010). Local radiation therapy inhibits tumor growth through the generation of tumor-specific CTL: its potentiation by combination with Th1 cell therapy. Cancer Res. 70, 2697-2706.
101. Tsukimoto, M., Homma, T., Mutou, Y., and Kojima, S. (2009). 0.5 Gy gamma radiation suppresses production of TNF-alpha through up-regulation of MKP-1 in mouse macrophage RAW264.7 cells. Radiat. Res. 171, 219-224.
102. Vabulas, R. M., Braedel, S., Hilf, N., Singh-Jasuja, H., Herter, S., Ahmad-Nejad, P., Kirschning, C. J., Da Costa, C., Rammensee, H. G., Wagner, H., and Schild, H. (2002). The endoplasmic reticulum-resident heat shock protein Gp96 activates dendritic cells via the Toll-like receptor 2/4 pathway. J. Biol. Chem. 277, 20847-20853.
103. Valledor, A. F., Comalada, M., Santamaria-Babi, L. F., Lloberas, J., and Celada, A. (2010). Macrophage proinflammatory activation and deactivation: a question of balance. Adv. Immunol. 108, 1-20.
104. Vanlangenakker, N., Vanden Berghe, T., and Vandenabeele, P. (2012). Many stimuli pull the necrotic trigger, an overview. Cell Death Differ. 19, 75-86.
105. Vega, V. L., Rodriguez-Silva, M., Frey, T., Gehrmann, M., Diaz, J. C., Steinem, C., Multhoff, G., Arispe, N., and De Maio, A. (2008). Hsp70 translocates into the plasma membrane after stress and is released into the extracellular environment in a membrane-associated form that activates macrophages. J. Immunol. 180, 4299-4307.
106. Vesely, M. D., Kershaw, M. H., Schreiber, R. D., and Smyth, M. J. (2011). Natural innate and adaptive immunity to cancer. Annu. Rev. Immunol. 29, 235-271.
107. Vodovotz, Y., and Bogdan, C. (1994). Control of nitric oxide synthase expression by transforming growth factor-beta: implications for homeostasis. Prog. Growth Factor Res. 5, 341-351.
108. Voll, R. E., Herrmann, M., Roth, E. A., Stach, C., Kalden, J. R., and Girkontaite, I. (1997). Immunosuppressive effects of apoptotic cells. Nature 390, 350-351.
109. Wersall, P. J., Blomgren, H., Pisa, P., Lax, I., Kalkner, K. M., and Svedman, C. (2006). Regression of non-irradiated metastases after extracranial stereotactic radiotherapy in metastatic renal cell carcinoma. Acta Oncol. 45, 493-497.
110. Wheeler, C. J., Das, A., Liu, G., Yu, J. S., and Black, K. L. (2004). Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination. Clin. Cancer Res. 10, 5316-5326.
111. Yagunov, A. S., Tokalov, S. V., and Chukhlovin, A. B. (1998). Animal Studies of Residual Hematopoietic and Immune System Injury from Low Dose/Low Dose Rate Radiation and Heavy Metals. AFFRI Contract Report 98-3. Bethesda: Armed Forces Radiobiology Research Institute.
112. Zitvogel, L., Kepp, O., Aymeric, L., Ma, Y., Locher, C., Delahaye, N. F., Andre, F., and Kroemer, G. (2010). Integration of host-related signatures with cancer cell-derived predictors for the optimal management of anticancer chemotherapy. Cancer Res. 70, 9538-9543.